Current treatment status-Undergoing active treatment - Page 24 of 29 Posts on Medivizor
Navigation Menu

Current treatment status-Undergoing active treatment Posts on Medivizor

Can hormone therapy increase the risk of heart disease and diabetes in prostate cancer?

Can hormone therapy increase the risk of heart disease and diabetes in prostate cancer?

Posted by on Jun 13, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the link between hormone therapy and metabolic syndrome in prostate cancer patients.  Some background Hormone therapy is a common treatment used in prostate cancer management. It blocks the male sex hormones active in prostate cancer, such as testosterone. In some patients hormone therapy can...

Read More

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Chemotherapy before surgery; is there a different in outcome between different types of breast cancer?

Posted by on May 14, 2015 in Breast cancer | 0 comments

In a nutshell The authors aimed to evaluate if the outcomes of surgery following chemotherapy are different based on the focality of breast cancer tumors.  Some background Breast cancer can be characterised as 'unifocal', 'multifocal and 'multicentric'. This refers to the number of areas in which the cancer can be found...

Read More

Identifying prostate cancer progression

Posted by on Apr 29, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to identify the best options available to identify metastatic prostate cancer. Some background Metastatic prostate cancer is cancer that has spread from the prostate gland into tissues and organs around the body. In some cases patients with metastatic cancer can become resistant to certain treatments, such as...

Read More

Maintenance therapy does not impair subsequent treatment with pemetrexed in metastatic lung cancer

Posted by on Feb 23, 2015 in Lung cancer | 0 comments

In a nutshell The authors aimed to determine whether previous maintenance therapy with gemcitabine or erlotinib impaired pemetrexed treatment.  Some background Maintenance therapy is the ongoing use of chemotherapy  or another treatment given to help the primary treatment succeed and prevent cancer recurrence. Two drugs have been...

Read More

Factors that affect survival following recurrence despite surgery for non-small cell lung cancer

Factors that affect survival following recurrence despite surgery for non-small cell lung cancer

Posted by on Feb 16, 2015 in Lung cancer | 1 comment

In a nutshell The authors aimed to determine factors that predicted survival after return of non-small cell lung cancer. Some background Non-small cell lung cancer (NSCLC) is the most common form of lung cancer. In cases of cancer recurrence (return), NSCLC can reoccur at different sites in the body from the primary site or can be limited to a...

Read More

BRCA mutations and response to conventional treatments for localised prostate cancer

BRCA mutations and response to conventional treatments for localised prostate cancer

Posted by on Jan 19, 2015 in Prostate cancer | 0 comments

In a nutshell The authors aimed to determine the effects of conventional treatment in localised prostate cancer patients with BRCA mutations. Some background BRCA mutations are mutations in the BRCA1 or BRCA2 gene (regulates cell functions). BRCA genes prevent tumors from growing. When they are mutated tumors can grow freely causing cancers such...

Read More

Can PSA level indicate either cure or the need for long term hormone suppression treatment?

Can PSA level indicate either cure or the need for long term hormone suppression treatment?

Posted by on Jan 12, 2015 in Prostate cancer | 1 comment

In a nutshell This study investigated if measuring the levels of prostate specific antigen (PSA) after cancer therapy could indicate a cure or if the patient should be considered for long term androgen deprivation (suppression) therapy. The main finding was that lower PSA blood levels predict better survival in patients with prostate cancer. Some...

Read More

Everolimus and adverse events

Everolimus and adverse events

Posted by on Sep 29, 2014 in Breast cancer | 0 comments

In a nutshell This paper reviewed adverse events associated with treatment of breast cancer with everolimus (Afinitus). Some background Everolimus is used in postmenopausal patients for advanced breast cancer treatments. The drug has been approved for use in patients with hormone receptor positive (the presence of the estrogen...

Read More